EPLBB05 Safety and effectiveness outcomes from the Carisel study: phase 3b hybrid-3 implementation study integrating cabotegravir + rilpivirine long-acting into European clinical settingsE-posterLong-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches)
EPC339 Safe index testing as a high yielding HIV case identification strategy, the successful implementation by Oljabet Health Center, Laikipia, KenyaE-posterFacility-based HIV testing strategies
EPA058 Rufinamide-induced autophagy cell death in HIV-1-infected macrophagesE-posterStrategies to reduce/eliminate viral reservoirs
EPF042 Routine domestic abuse (DA) enquiring in people living with HIV (PLWH)E-posterSexual- and/or gender-based inequalities, inequities and violence
PESUA17 Role of UHRF1 in HIV-1 transcriptional regulationPoster exhibitionHost cellular factors and viral mechanisms of HIV/SIV persistence and latency
PESUA16 Role of the polgene enhancer in HIV-1 transcription and replication in myeloid infected cellsPoster exhibitionHost cellular factors and viral mechanisms of HIV/SIV persistence and latency
EPA078 Role of PD-1, TIGIT and TIM3 on NK cell exhaustion and function in HIV/HCV coinfection, and the impact of HCV elimination in the long termE-posterHIV and co-infections (TB, viral hepatitis, SARS-CoV2, other)
EPD013 Role of Female health workers during HIV/AIDS EPIDEMICS in Sindh PakistanE-posterKnowledge translation and dissemination of research and programme outcomes
EPC304 Role of disclosure, stigma, discrimination on ART adherence among people living with HIV in sub-Saharan Africa: a qualitative systematic reviewE-posterPrevention of vertical transmission
EPF126 Road to ending compulsory drug treatment in East and Southeast AsiaE-posterPunitive laws and enforcement practices directed at or impacting on key populations)
581 - 590 of 2485 items